CAMP4 THERAPEUTICS Cash Per Share Over Time

CAMP Stock  USD 8.30  0.73  8.08%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CAMP4 THERAPEUTICS Performance and CAMP4 THERAPEUTICS Correlation.
  
As of 12/10/2024, Cash Per Share is likely to grow to 3.37.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CAMP4 THERAPEUTICS. If investors know CAMP4 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CAMP4 THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CAMP4 THERAPEUTICS is measured differently than its book value, which is the value of CAMP4 that is recorded on the company's balance sheet. Investors also form their own opinion of CAMP4 THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is CAMP4 THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CAMP4 THERAPEUTICS's market value can be influenced by many factors that don't directly affect CAMP4 THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CAMP4 THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if CAMP4 THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CAMP4 THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Cash Per Share Analysis

Compare CAMP4 THERAPEUTICS and related stocks such as DZS Inc, Harmonic, and CommScope Holding Cash Per Share Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Capex To DepreciationPb Ratio
RoicInventory Turnover
Net Income Per SharePayables Turnover
Sales General And Administrative To RevenueResearch And Ddevelopement To Revenue
PocfratioInterest Coverage
Capex To Operating Cash FlowPfcf Ratio
Income QualityRoe
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Current RatioReceivables Turnover
Debt To EquityRevenue Per Share
Debt To AssetsDividend Yield
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueEv To Sales
Free Cash Flow Per ShareDays Of Inventory On Hand
Average InventoryCapex To Revenue
Cash Per SharePayout Ratio
Days Payables OutstandingNet Current Asset Value
Tangible Asset ValueNet Debt To E B I T D A
Tangible Book Value Per ShareGraham Number
Shareholders Equity Per ShareCapex Per Share
Graham Net NetAverage Receivables
Interest Debt Per ShareEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Days Of Payables OutstandingDividend Payout Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Enterprise Value Multiple
201020112012201320142015201620172018201920202021202220232024
HLIT0.97021.40511.73971.60131.13391.75610.80510.70420.77081.03891.01731.31480.85260.75480.72
COMM1.7081.7081.48162.15593.90212.96452.22492.35952.38643.08832.65191.76961.91952.57851.92
NTGR0.93869.52829.9036.46597.18828.391411.172310.2758.67536.326211.81788.97847.84039.66275.91
CMTL0.36718.399321.02479.69089.31643.97131.78571.82511.88921.93071.20150.81690.67711.12621.07
MYNA0.03640.03640.03640.03640.12320.26370.08610.51955.11953.338812.920211.33871.91513.96453.61
KN0.12120.12120.12121.24180.64910.72920.74661.25040.81620.86011.61180.74650.52560.96040.68
ITRN0.0671.68531.40472.22621.94491.38551.50161.92982.52862.58223.78832.63431.37952.67771.51
AVNW10.05462.93062.93062.93062.93062.93064.27784.27784.27784.27784.27784.27785.30475.30473.6205
FEIM2.11842.69422.5832.78272.13771.96991.13551.58591.33261.58452.19232.3231.29041.93222.43
DGII0.05674.60783.40293.17173.74155.20614.17062.3173.32531.87634.7470.99630.88480.75750.72
ADTN5.0E-43.15423.61912.78062.18362.32572.52612.12992.27132.23711.31871.17231.74811.11161.46
KVHI0.15752.072.59083.68093.22972.90163.29252.61371.05882.76492.13481.34624.11853.64723.83
TSAT1.57131.57131.57132.49924.16055.77816.53794.004166.099686.268668.767121136120126

CAMP4 THERAPEUTICS and related stocks such as DZS Inc, Harmonic, and CommScope Holding Cash Per Share description

My Equities

My Current Equities and Potential Positions

CAMP4 THERAPEUTICS PORATION
CAMP
Specialization
Healthcare, Biotechnology
LocationMassachusetts; U.S.A
ExchangeNASDAQ Exchange
USD 8.3

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.